mAb Biosimilars Market 2016-2020

  • Published: Sep 2016
  • Pages: 103
  • SKU: IRTNTR10349

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

This market research report analyzes the leading vendors in the global mAb biosimilars market such as Biocon, Celltrion, Dr. Reddys Laboratories, and Hospira. A comprehensive analysis of this market is also presented by application (chronic and autoimmune diseases and oncology) and by geography (Asia, Europe, and ROW).

Overview of the mAb biosimilars market

Extensive research carried out by the analysts at Technavio has shown that the global mAb biosimilars market is anticipated to witness tremendous growth and will post a staggering CAGR of more than 57% over the forecast period. The increasing need for cost-effective treatment is one of the major factors driving this market’s growth. Biosimilars are available at a 10% to 30% discount, leading to their increased adoption. For instance, Inflectra was one of the first biosimilar products to receive marketing authorization in the US market, and it costs around 25% less than the original product. As biosimilar products are positioned as a cost-effective treatment option, its market is likely to grow significantly over the next four years.

One of the recent trends impelling the growth of this market is the rising number of strategic collaborations. Vendors in the market are forming strategic alliances to increase their market share, for example, in 2011, Amgen and Watson Pharmaceuticals reached an agreement to develop and commercialize biosimilar treatments for cancer. As a part of this agreement, Amgen is expected to develop and manufacture biosimilars with Watson and provide marketing and financial support for the products launched.

Competitive landscape and key vendors

The global mAb biosimilars market is characterized by the presence of several well-established vendors. The vendors focus on selling their products to commercial laboratories and hospitals whose numbers have increased in the recent past and will increase in future due to greater healthcare spending and improved infrastructure in a bid to expand their reach in the market.

 Key vendors in this market are -

  • Biocon
  • Celltrion
  • Dr. Reddy's Laboratories
  • Hospira

Other prominent vendors in the market include 3SBio, Accord Healthcare, AET Biotech, Allergan, Alvartis Pharma, Amega Biotech, Amgen, Apotex, Aspen, AstraZeneca, Aurobindo Pharma, Baxter, Bharat Serums, Bio Sidus, Biogen, Bionovis, Bioton, BioXpress Therapeutics, Boehringer Ingelheim, Boston Oncology, Cipla, Coherus Biosciences, Daiichi Sankyo, Emcure Pharmaceuticals, Gedeon Richter, GeneScience Pharmaceuticals, GSK, Hetero Drugs, iBio, Intas Pharmaceuticals, JCR Pharmaceuticals, LG Lifesciences, Lonza, Merck, Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Mylan, Natco Pharma, Novartis, Pfenex, Pfizer, Ranbaxy Laboratories, Roche Holding, Samsung Biologics, Sanofi, and Synthon.

Segmentation by application and analysis of the mAb biosimilars market

  • Chronic and autoimmune diseases
  • Oncology

During 2015, the chronic and autoimmune diseases segment was the highest revenue contributor and is expected to the lead the market in the coming years. The growth of this segment is attributed to a rise in the geriatric population, the improved standards of healthcare facilities, and the availability of sophisticated treatment options. The rise in the older population has consequently led to an increase in the incidence of diseases such as chronic arthritis, osteoarthritis, diabetic neuropathy, cancer, and autoimmune diseases, which, in turn, will propel this sector’s growth over the predicted period.

Geographical segmentation and analysis of the mAb biosimilars market

  • Asia
  • Europe
  • ROW

In terms of geography, Europe dominated the global mAb market and is expected to continue its dominance until 2020. The market will witness significant growth in countries such as the UK, Germany, Spain, France, and Italy. The introduction of new biosimilars will boost this market’s growth in the region. Also, well-defined and flexible regulatory guidelines are some of the major factors contributing to this market’s growth in Europe.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020?
  • What are the key factors driving the global mAb biosimilars market?
  • What are the key market trends impacting the growth of the global mAb biosimilars market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global mAb biosimilars market?
  • What are the market opportunities and threats faced by the vendors in the global mAb biosimilars market?
  • What are the trending factors influencing the market shares of the Asia, Europe, and ROW?
  • What are the key outcomes of the five forces analysis of the global mAb biosimilars market?

Technavio also offers customization on reports based on specific client requirement.

Related reports:

Biosimilars can be termed as the follow-on versions of original biological medicines. These are developed after the patent protecting the original product has expired or is set to expire. mAb, i.e., biosimilar monoclonal antibodies are complex proteins that recognize and counterbalance foreign bodies, such as bacteria and viruses. mAb is used by the immune system and is a part of the biosimilar family. They are also used in the treatment of life-threatening diseases like cancer and other illness such as rheumatoid arthritis. In simple terms, mAbs could be seen as “shields” used by the immune system to fight the aforementioned diseases.

The report, global mAb biosimilars market, is part of Technavio’s healthcare and life sciences research portfolio. This portfolio provides a comprehensive market analysis along with the market share, market sizing, and market segmentations covering areas such as cardiovascular and metabolic disorders, central nervous system, oncology, medical imaging, life science research tools, and vaccines. These market research reports provide a perspective on the various market opportunities and market threats along with the key trends that would influence the market growth during the forecast period. It presents insights into the changing competitive landscape and a detailed profiling and market analysis of the vendors. Also covered in the research are the key regions or countries that would have an impact on the market during the assessment years.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings
  • Assumptions

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Biosimilars: Overview
  • Comparative analysis of generic small molecules and biosimilars
  • Biosimilars market opportunities
  • Challenges for new entrants
  • Bio-betters

PART 05: Pipeline portfolio

PART 06: Market landscape

  • Market overview
  • Five forces analysis

PART 07: Market segmentation by application

  • Global chronic and autoimmune diseases mAb biosimilars market
  • Global oncology mAb biosimilars market

PART 08: Geographical segmentation

  • Global mAb biosimilars market by geographical segmentation 2015-2020
  • mAb biosimilars market in Europe
  • mAb biosimilars market in Asia
  • mAb biosimilars market in rest of the world

PART 09: Market drivers

  • Rise in number of patent expiries
  • Need for cost-effective treatment
  • Reimbursement benefits for biosimilars
  • Favorable government regulations

PART 10: Impact of drivers

PART 11: Market challenges

  • Physicians' reluctance to prescribe biosimilars
  • Multiple manufacturing complexities
  • Risks related to drug failure
  • Limited availability of biosimilar products
  • Difficulties in patient recruitment for clinical trials

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Emergence of biosimilars
  • Outsourcing of manufacturing activities
  • Need for high investment in R&D
  • High growth in the emerging markets
  • Rising number of strategic collaborations

PART 14: Vendor landscape

  • Competitive scenario

PART 15: Key vendor analysis

  • Biocon
  • Celltrion
  • Dr. Reddy's Laboratories
  • Hospira
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted

  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>